Annual Operating Profit
-$18.25 M
-$1.68 M-10.12%
31 March 2024
Summary:
Portage Biotech annual operaing income is currently -$18.25 million, with the most recent change of -$1.68 million (-10.12%) on 31 March 2024. During the last 3 years, it has fallen by -$5.81 million (-46.73%). PRTG annual operating profit is now -61151.68% below its all-time high of -$29.80 thousand, reached on 31 March 2007.PRTG Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$1.61 M
+$1.24 M+43.41%
30 September 2024
Summary:
Portage Biotech quarterly operating income is currently -$1.61 million, with the most recent change of +$1.24 million (+43.41%) on 30 September 2024. Over the past year, it has increased by +$4.33 million (+72.90%). PRTG quarterly operating profit is now -214.78% below its all-time high of $1.40 million, reached on 31 March 2006.PRTG Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$11.76 M
+$4.33 M+26.93%
30 September 2024
Summary:
Portage Biotech TTM operating income is currently -$11.76 million, with the most recent change of +$4.33 million (+26.93%) on 30 September 2024. Over the past year, it has increased by +$8.03 million (+40.58%). PRTG TTM operating profit is now -1380.97% below its all-time high of $917.90 thousand, reached on 31 December 2006.PRTG TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTG Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.1% | +72.9% | +40.6% |
| 3 y3 years | -46.7% | +51.6% | +31.7% |
| 5 y5 years | -560.4% | -2.6% | -103.9% |
PRTG Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -46.7% | at low | at high | +72.9% | at high | +42.7% |
| 5 y | 5 years | -560.4% | at low | -86.0% | +82.9% | -159.3% | +42.7% |
| alltime | all time | <-9999.0% | +48.6% | -214.8% | +94.5% | -1381.0% | +66.9% |
Portage Biotech Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.61 M(-43.4%) | -$11.76 M(-26.9%) |
| June 2024 | - | -$2.85 M(-12.7%) | -$16.09 M(-11.8%) |
| Mar 2024 | -$18.25 M(+10.1%) | -$3.26 M(-19.3%) | -$18.25 M(-4.3%) |
| Dec 2023 | - | -$4.04 M(-32.0%) | -$19.07 M(-3.6%) |
| Sept 2023 | - | -$5.95 M(+18.7%) | -$19.79 M(+13.1%) |
| June 2023 | - | -$5.01 M(+22.9%) | -$17.50 M(+5.6%) |
| Mar 2023 | -$16.58 M(+6.3%) | -$4.08 M(-14.4%) | -$16.58 M(-2.5%) |
| Dec 2022 | - | -$4.76 M(+30.3%) | -$17.00 M(+3.6%) |
| Sept 2022 | - | -$3.65 M(-10.6%) | -$16.41 M(+2.0%) |
| June 2022 | - | -$4.09 M(-9.1%) | -$16.08 M(+3.2%) |
| Mar 2022 | -$15.59 M(+25.3%) | -$4.50 M(+7.8%) | -$15.59 M(-24.1%) |
| Dec 2021 | - | -$4.17 M(+25.2%) | -$20.52 M(+19.2%) |
| Sept 2021 | - | -$3.33 M(-7.3%) | -$17.22 M(+14.4%) |
| June 2021 | - | -$3.59 M(-61.9%) | -$15.06 M(+21.1%) |
| Mar 2021 | -$12.44 M(+108.1%) | -$9.43 M(+989.3%) | -$12.44 M(+174.3%) |
| Dec 2020 | - | -$866.00 K(-25.9%) | -$4.54 M(-4.5%) |
| Sept 2020 | - | -$1.17 M(+20.0%) | -$4.75 M(-7.8%) |
| June 2020 | - | -$973.00 K(-36.3%) | -$5.15 M(-13.8%) |
| Mar 2020 | -$5.98 M(+116.3%) | -$1.53 M(+41.2%) | -$5.98 M(-9.3%) |
| Dec 2019 | - | -$1.08 M(-31.1%) | -$6.59 M(+14.3%) |
| Sept 2019 | - | -$1.57 M(-12.7%) | -$5.77 M(+31.4%) |
| June 2019 | - | -$1.80 M(-16.0%) | -$4.39 M(+59.3%) |
| Mar 2019 | -$2.76 M(+23.7%) | -$2.14 M(+729.8%) | -$2.76 M(+49.1%) |
| Dec 2018 | - | -$258.00 K(+33.7%) | -$1.85 M(-4.4%) |
| Sept 2018 | - | -$193.00 K(+17.7%) | -$1.93 M(-6.8%) |
| June 2018 | - | -$164.00 K(-86.7%) | -$2.07 M(-7.2%) |
| Mar 2018 | -$2.23 M(-93.7%) | -$1.23 M(+259.8%) | -$2.23 M(-92.7%) |
| Dec 2017 | - | -$343.00 K(+3.0%) | -$30.58 M(+0.3%) |
| Sept 2017 | - | -$333.00 K(+2.5%) | -$30.49 M(-0.8%) |
| June 2017 | - | -$325.00 K(-98.9%) | -$30.75 M(-13.4%) |
| Mar 2017 | -$35.50 M(+286.4%) | -$29.57 M(>+9900.0%) | -$35.50 M(+360.2%) |
| Dec 2016 | - | -$259.00 K(-56.1%) | -$7.71 M(-37.2%) |
| Sept 2016 | - | -$590.00 K(-88.4%) | -$12.29 M(-7.1%) |
| June 2016 | - | -$5.07 M(+183.3%) | -$13.23 M(+44.0%) |
| Mar 2016 | -$9.19 M(+112.8%) | -$1.79 M(-62.9%) | -$9.19 M(+4.0%) |
| Dec 2015 | - | -$4.83 M(+215.3%) | -$8.84 M(+80.6%) |
| Sept 2015 | - | -$1.53 M(+48.3%) | -$4.89 M(+13.3%) |
| June 2015 | - | -$1.03 M(-28.2%) | -$4.32 M(+0.0%) |
| Mar 2015 | -$4.32 M(+55.1%) | -$1.44 M(+62.2%) | -$4.32 M(-11.0%) |
| Dec 2014 | - | -$887.20 K(-7.4%) | -$4.85 M(+14.2%) |
| Sept 2014 | - | -$958.00 K(-7.2%) | -$4.25 M(+16.8%) |
| June 2014 | - | -$1.03 M(-47.7%) | -$3.64 M(+30.7%) |
| Mar 2014 | -$2.78 M(+125.4%) | -$1.97 M(+597.0%) | -$2.78 M(+104.2%) |
| Dec 2013 | - | -$283.20 K(-18.6%) | -$1.36 M(+74.7%) |
| Sept 2013 | - | -$347.90 K(+94.6%) | -$780.30 K(-68.3%) |
| June 2013 | - | -$178.80 K(-67.7%) | -$2.46 M(-1.2%) |
| Mar 2013 | -$1.24 M | -$553.50 K(-284.6%) | -$2.49 M(+10.3%) |
| Dec 2012 | - | $299.90 K(-114.8%) | -$2.26 M(-21.8%) |
| Sept 2012 | - | -$2.03 M(+874.0%) | -$2.88 M(+122.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | -$208.20 K(-35.0%) | -$1.30 M(-20.1%) |
| Mar 2012 | -$1.60 M(-35.6%) | -$320.30 K(-2.3%) | -$1.62 M(+29.9%) |
| Dec 2011 | - | -$327.70 K(-25.7%) | -$1.25 M(-38.1%) |
| Sept 2011 | - | -$441.00 K(-17.4%) | -$2.02 M(-16.4%) |
| June 2011 | - | -$534.00 K(-1101.9%) | -$2.41 M(-0.8%) |
| Mar 2011 | -$2.49 M(-24.1%) | $53.30 K(-104.9%) | -$2.43 M(-50.1%) |
| Dec 2010 | - | -$1.10 M(+30.9%) | -$4.88 M(+13.4%) |
| Sept 2010 | - | -$837.60 K(+51.5%) | -$4.30 M(+3.0%) |
| June 2010 | - | -$553.00 K(-76.9%) | -$4.18 M(+9.9%) |
| Mar 2010 | -$3.28 M(+563.4%) | -$2.39 M(+361.4%) | -$3.80 M(+144.1%) |
| Dec 2009 | - | -$518.70 K(-27.3%) | -$1.56 M(+23.1%) |
| Sept 2009 | - | -$713.60 K(+303.8%) | -$1.26 M(+79.7%) |
| June 2009 | - | -$176.70 K(+19.1%) | -$703.90 K(-2.3%) |
| Mar 2009 | -$494.20 K(-10.8%) | -$148.40 K(-34.4%) | -$720.20 K(+37.1%) |
| Dec 2008 | - | -$226.10 K(+48.1%) | -$525.40 K(+11.6%) |
| Sept 2008 | - | -$152.70 K(-20.9%) | -$470.70 K(+1.2%) |
| June 2008 | - | -$193.00 K(-515.9%) | -$465.20 K(+9.0%) |
| Mar 2008 | -$553.90 K(+1758.7%) | $46.40 K(-127.1%) | -$426.80 K(+3710.7%) |
| Dec 2007 | - | -$171.40 K(+16.4%) | -$11.20 K(-5700.0%) |
| Sept 2007 | - | -$147.20 K(-4.8%) | $200.00(-101.0%) |
| June 2007 | - | -$154.60 K(-133.5%) | -$19.80 K(-16.1%) |
| Mar 2007 | -$29.80 K(-95.1%) | $462.00 K(-388.8%) | -$23.60 K(-102.6%) |
| Dec 2006 | - | -$160.00 K(-4.3%) | $917.90 K(+18.6%) |
| Sept 2006 | - | -$167.20 K(+5.6%) | $774.00 K(+96.5%) |
| June 2006 | - | -$158.40 K(-111.3%) | $393.80 K(-172.3%) |
| Mar 2006 | -$607.00 K(-84.9%) | $1.40 M(-561.8%) | -$544.50 K(-89.9%) |
| Dec 2005 | - | -$303.90 K(-44.5%) | -$5.40 M(+4.0%) |
| Sept 2005 | - | -$547.40 K(-50.1%) | -$5.19 M(+6.4%) |
| June 2005 | - | -$1.10 M(-68.2%) | -$4.88 M(+20.4%) |
| Mar 2005 | -$4.01 M(+274.8%) | -$3.45 M(+3492.8%) | -$4.05 M(+171.5%) |
| Dec 2004 | - | -$96.10 K(-58.9%) | -$1.49 M(+3.3%) |
| Sept 2004 | - | -$233.80 K(-12.9%) | -$1.45 M(+11.3%) |
| June 2004 | - | -$268.50 K(-70.0%) | -$1.30 M(+22.8%) |
| Mar 2004 | -$1.07 M(+394.4%) | -$893.80 K(+1724.1%) | -$1.06 M(+431.8%) |
| Dec 2003 | - | -$49.00 K(-43.9%) | -$198.80 K(-14.9%) |
| Sept 2003 | - | -$87.40 K(+223.7%) | -$233.70 K(+17.3%) |
| June 2003 | - | -$27.00 K(-23.7%) | -$199.20 K(-8.6%) |
| Mar 2003 | -$216.60 K(-67.6%) | -$35.40 K(-57.8%) | -$217.90 K(-49.6%) |
| Dec 2002 | - | -$83.90 K(+58.6%) | -$432.50 K(-35.3%) |
| Sept 2002 | - | -$52.90 K(+15.8%) | -$668.00 K(-0.1%) |
| June 2002 | - | -$45.70 K(-81.7%) | -$668.50 K(-0.4%) |
| Mar 2002 | -$669.20 K(+83.7%) | -$250.00 K(-21.7%) | -$671.50 K(+72.5%) |
| Dec 2001 | - | -$319.40 K(+498.1%) | -$389.20 K(+136.3%) |
| Sept 2001 | - | -$53.40 K(+9.7%) | -$164.70 K(+48.0%) |
| June 2001 | - | -$48.70 K(-250.8%) | -$111.30 K(+77.8%) |
| Mar 2001 | -$364.20 K(-62.0%) | $32.30 K(-134.0%) | -$62.60 K(-34.0%) |
| Dec 2000 | - | -$94.90 K | -$94.90 K |
| Mar 2000 | -$957.30 K(+202.5%) | - | - |
| Mar 1999 | -$316.50 K(-18.8%) | - | - |
| Mar 1998 | -$389.60 K | - | - |
FAQ
- What is Portage Biotech annual operaing income?
- What is the all time high annual operating profit for Portage Biotech?
- What is Portage Biotech annual operating profit year-on-year change?
- What is Portage Biotech quarterly operating income?
- What is the all time high quarterly operating profit for Portage Biotech?
- What is Portage Biotech quarterly operating profit year-on-year change?
- What is Portage Biotech TTM operating income?
- What is the all time high TTM operating profit for Portage Biotech?
- What is Portage Biotech TTM operating profit year-on-year change?
What is Portage Biotech annual operaing income?
The current annual operating profit of PRTG is -$18.25 M
What is the all time high annual operating profit for Portage Biotech?
Portage Biotech all-time high annual operaing income is -$29.80 K
What is Portage Biotech annual operating profit year-on-year change?
Over the past year, PRTG annual operaing income has changed by -$1.68 M (-10.12%)
What is Portage Biotech quarterly operating income?
The current quarterly operating profit of PRTG is -$1.61 M
What is the all time high quarterly operating profit for Portage Biotech?
Portage Biotech all-time high quarterly operating income is $1.40 M
What is Portage Biotech quarterly operating profit year-on-year change?
Over the past year, PRTG quarterly operating income has changed by +$4.33 M (+72.90%)
What is Portage Biotech TTM operating income?
The current TTM operating profit of PRTG is -$11.76 M
What is the all time high TTM operating profit for Portage Biotech?
Portage Biotech all-time high TTM operating income is $917.90 K
What is Portage Biotech TTM operating profit year-on-year change?
Over the past year, PRTG TTM operating income has changed by +$8.03 M (+40.58%)